Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: Results of a phase I/II study

International Journal of Cancer

Volumn 65, Issue 4, 1996, Pages 450-453

  Gjertsen, Marianne K ^a   Bakka, Arne ^a   Breivik, Jarle ^a   Saeterdal, Ingvil ^a   Gedde Dahl III, Tobias ^a   Stokke, Kjell T ^b   Solheim, Bjarte G ^c   Egge, Tor S ^a   Søreide, Odd ^a   Thorsby, Erik ^a   Gaudernack, Gustav ^a,d  

^a UNIVERSITY OF OSLO   (Norway)

^b Pronova as ^*  (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d INSTITUTE OF CANCER RESEARCH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; RAS PROTEIN; SYNTHETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VACCINATION;

ADULT; AGED; AMINO ACID SEQUENCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PILOT PROJECTS; RAS PROTEINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 13344270400     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960208)65:4<450::AID-IJC10>3.0.CO;2-E     Document Type: Article

References (15)

1. ALMOGUERA, C., SHIBATA, D., FORRESTER, K., MARTIN, J., ARNHEIM, N, and PERUCHO, M., Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53, 549-554 (1988).
2. CAPELLA, G., CRONAUER-MITRA, S., PEINADO, M.A., and PERUCHO, M., Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ. Health Perspeci., 93, 125-131 (1991).
3. - T cells recognize a peptide corresponding to a common mutation (13Gly → Asp). Int J. Cancer, 56, 40-45 (1994).
4. FOSSUM, B., GEDDE-DAHL III, T., HANSEN, T., ERIKSEN, J.A., THORSBY, E. and GAUDERNACK, G., Overlapping epitopes encompassing a point mutation (12Gly → Arg) in p21 ras can be recognized by HLA-DR. -DP, and -DQ restricted T cells. Europ. J. Immunol., 23, 2687-2691 (1993).
5. - T cells from a patient with colon carcinoma, specific for a mutant p21 ras derived peptide (13Gly → Asp), are cytotoxic towards a carcinoma cell line harbouring the same mutation. Cancer. Immunol. Immunother. 40, 165-172 (1995).
6. GEDDE-DAHL III, T., ERIKSEN, J.A., THORSBY, E. and GAUDERNACK. G., T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides. Hum. Immunol., 33, 266-274 (1992a).
7. GEDDE-DAHL III, T., NILSEN, E., THORSBY, E. and GAUDERNACK, G . Growth inhibition of a colonic adenocarcinoma cell line (HT29) by T cells specific for mutant p21 ras. Cancer. Immunol. Immunother., 38, 127-134 (1994a).
8. GEDDE-DAHL III, T., SPURKLAND, A., ERIKSEN, J.A., THORSBY, E. and GAUDERNACK, G., Memory T cells of a patient with follicuiar thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln → Leu61). Int. Immunol., 4, 1331-1337 (1992b).
9. GEDDE-DAHL III, T., SPURKLAND, A., FOSSUM, B., WITTINGHOFER, A., THORSBY, E. and GAUDERNACK, G., T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA. Europ. J. ImmunoL 24, 410-414 (1994b).
10. JUNG, S. and SCHLUESENER, H.J., Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins. J. exp. Med., 73, 273-276 (1991).
11. KAHN, S.M., JIANG, W., CULBERTSON, T.A., WEINSTEIN, B., WILLIAMS, G.M., TOMITA, N. and RONAI, Z., Rapid an sensitive non-radioactive detection of mutant K-ras genes via "enriched" PCR amplification. Oncogene, 6, 1079-1083 (1991).
12. KARNOFSKY, D.A., ABELMANN, W.H., GRAVER, L.F. and BURCHENAL, J.H., The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer, 1, 634-656 (1948).
13. MILLER, A.B., HOOGSTRATEN, B., STAQUET, M. and WINKLER, A., Reporting results of cancer treatment. Cancer, 47, 207-214 (1981).
14. SLAMON, D.J., DE KERNION, J.B., VERMA, I.M. and CLINE, M.J., Expression of cellular oncogenes in human malignancies. Science, 224, 256-262 (1984).
15. WARSHAW, A. and FERNANDEZ DEL CASTILLO, C., Pancreatic cancer. New Engl. J. Med., 326, 455-465 (1992).